Evidence map›Paper›PMID 29018317›Full record

ArticleFrontiers in neuroscience2017

JAKE® Multimodal Data Capture System: Insights from an Observational Study of Autism Spectrum Disorder.

Seth L Ness, Nikolay V Manyakov, Abigail Bangerter, David Lewin, Shyla Jagannatha, Matthew Boice, Andrew Skalkin, Geraldine Dawson, Yvette M Janvier, Matthew S Goodwin and 5 more

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Frontiers in psychology · 2023
    Article
  5. Article
  6. Review
  7. Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2021
    Review
  8. Electrophysiological Biomarkers in Genetic Epilepsies.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Seth L NessNeuroscience Therapeutic Area, Janssen Research and Development, Titusville, NJ, United States.
Nikolay V ManyakovComputational Biology, Discovery Sciences, Janssen Research and Development, Beerse, Belgium.
Abigail BangerterNeuroscience Therapeutic Area, Janssen Research and Development, Titusville, NJ, United States.
David LewinClinical Biostatistics, Janssen Research and Development, Titusville, NJ, United States.
Shyla JagannathaStatistical Decision Sciences, Janssen Research and Development, Titusville, NJ, United States.
Matthew BoiceNeuroscience Therapeutic Area, Janssen Research and Development, Titusville, NJ, United States.
Andrew SkalkinInformatics, Janssen Research and Development, Spring House, PA, United States.
Geraldine DawsonDepartments of Psychiatry and Behavioral Sciences, Duke Center for Autism and Brain Development, Duke University School of Medicine, Durham, NC, United States.
Yvette M JanvierDepartment of Psychiatry, Children's Specialized Hospital, Toms River, NJ, United States.
Matthew S GoodwinDepartment of Health Sciences, Northeastern University, Boston, MA, United States.
Robert HendrenDepartment of Psychiatry, School of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Bennett LeventhalDepartment of Psychiatry, School of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Frederick ShicDepartment of Pediatrics, Center for Child Health, Behavior and Development, Seattle Children's Research Institute, University of Washington, Seattle, WA, United States.
Walter CiocciaGlobal Digital Health, Janssen Research and Development, Raritan, NJ, United States.
Gahan PandinaGlobal Digital Health, Janssen Research and Development, Raritan, NJ, United States.

Funding

Recruitment and Assessment CoreP50HD093074 · NICHD · DUKE UNIVERSITY · PI Geraldine Dawson · 2017 to 2026
$27.6M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

assessmentautism spectrum disorder (ASD)biomarkerbiosensorsoftware

Identifiers

PMID29018317
PMCPMC5623040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.